AIM-HI Accelerator Fund shared a post on LinkedIn:
“The AIM-HI Accelerator Fund is now accepting applications for the 2026 AIM-HI Venture Competition, including the Women’s Venture Competition and the BRACE Award.
AIM-HI is more than capital. We support early-stage oncology founders with catalytic investment, hands-on mentorship, and access to a global network of scientific, clinical, and biotech leaders, from pre-seed through Series A.
If you are building breakthrough cancer solutions and looking for a mission-aligned partner who understands the science, the clinic, and the path to impact, we invite you to apply.
Applications are now open to early-stage oncology companies worldwide.”
More posts featuring AIM-HI Accelerator Fund.